Benzinga's Top Pre-Market NASDAQ Gainers (SGEN, JBLU, GFRE, ATPG)

Seattle Genetics Inc SGEN rose 11.84% to $13.60 in the pre-market session. SGEN announced that its cancer drug, SGN-35 met prime goals in a crucial study. JetBlue Airways Corporation JBLU added 7.91% to $6.41 in the pre-market session. According to Barron, JBLU is likely to benefit from targeting more premium-paying commercial travelers. Gulf Resources, Inc GFRE soared 7.22% to $6.98 in the pre-market trading. GFRE's board has approved a share repurchase program of up to $10 million. ATP Oil & Gas Corp ATPG moved up 3.92% to $13.00 in the pre-market session. The formation of ATP Titan LLC is announced by ATPG in order to monetize its investment in the ATP Titan. Read more from Benzinga's Markets. Click here to get trading ideas that could bring you a 100% return.